224 related articles for article (PubMed ID: 24191907)
1. Intrapleural administration of an AAVrh.10 vector coding for human α1-antitrypsin for the treatment of α1-antitrypsin deficiency.
Chiuchiolo MJ; Kaminsky SM; Sondhi D; Hackett NR; Rosenberg JB; Frenk EZ; Hwang Y; Van de Graaf BG; Hutt JA; Wang G; Benson J; Crystal RG
Hum Gene Ther Clin Dev; 2013 Dec; 24(4):161-73. PubMed ID: 24191907
[TBL] [Abstract][Full Text] [Related]
2. High levels of persistent expression of alpha1-antitrypsin mediated by the nonhuman primate serotype rh.10 adeno-associated virus despite preexisting immunity to common human adeno-associated viruses.
De BP; Heguy A; Hackett NR; Ferris B; Leopold PL; Lee J; Pierre L; Gao G; Wilson JM; Crystal RG
Mol Ther; 2006 Jan; 13(1):67-76. PubMed ID: 16260185
[TBL] [Abstract][Full Text] [Related]
3. Intrapleural administration of a serotype 5 adeno-associated virus coding for alpha1-antitrypsin mediates persistent, high lung and serum levels of alpha1-antitrypsin.
De B; Heguy A; Leopold PL; Wasif N; Korst RJ; Hackett NR; Crystal RG
Mol Ther; 2004 Dec; 10(6):1003-10. PubMed ID: 15564132
[TBL] [Abstract][Full Text] [Related]
4. Phase I/II study of intrapleural administration of a serotype rh.10 replication-deficient adeno-associated virus gene transfer vector expressing the human α1-antitrypsin cDNA to individuals with α1-antitrypsin deficiency.
Chiuchiolo MJ; Kaminsky SM; Sondhi D; Mancenido D; Hollmann C; Crystal RG
Hum Gene Ther Clin Dev; 2014 Sep; 25(3):112-33. PubMed ID: 25238276
[No Abstract] [Full Text] [Related]
5. Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin.
Sosulski ML; Stiles KM; Frenk EZ; Hart FM; Matsumura Y; De BP; Kaminsky SM; Crystal RG
JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32759494
[TBL] [Abstract][Full Text] [Related]
6. Intrapleural 'outside-in' gene therapy: therapeutics for organs of the chest via gene transfer to the pleura.
Heguy A; Crystal RG
Curr Opin Mol Ther; 2005 Oct; 7(5):440-53. PubMed ID: 16248279
[TBL] [Abstract][Full Text] [Related]
7. Efficient hepatic delivery and expression from a recombinant adeno-associated virus 8 pseudotyped alpha1-antitrypsin vector.
Conlon TJ; Cossette T; Erger K; Choi YK; Clarke T; Scott-Jorgensen M; Song S; Campbell-Thompson M; Crawford J; Flotte TR
Mol Ther; 2005 Nov; 12(5):867-75. PubMed ID: 16085464
[TBL] [Abstract][Full Text] [Related]
8. Safety of Intravenous Administration of an AAV8 Vector Coding for an Oxidation-Resistant Human α1-Antitrypsin for the Treatment of α1-Antitrypsin Deficiency.
Rosenberg JB; De BP; Greco A; Gorman N; Kooner V; Chen A; Yost-Bido M; Munoz-Zuluaga C; Kaminsky SM; Rostami M; Monette S; Crystal RG; Sondhi D
Hum Gene Ther; 2023 Feb; 34(3-4):139-149. PubMed ID: 36606685
[TBL] [Abstract][Full Text] [Related]
9. 5 Year Expression and Neutrophil Defect Repair after Gene Therapy in Alpha-1 Antitrypsin Deficiency.
Mueller C; Gernoux G; Gruntman AM; Borel F; Reeves EP; Calcedo R; Rouhani FN; Yachnis A; Humphries M; Campbell-Thompson M; Messina L; Chulay JD; Trapnell B; Wilson JM; McElvaney NG; Flotte TR
Mol Ther; 2017 Jun; 25(6):1387-1394. PubMed ID: 28408179
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector.
Lu Y; Choi YK; Campbell-Thompson M; Li C; Tang Q; Crawford JM; Flotte TR; Song S
J Gene Med; 2006 Jun; 8(6):730-5. PubMed ID: 16518879
[TBL] [Abstract][Full Text] [Related]
11. Alpha1-antitrypsin deficiency: biological answers to clinical questions.
Coakley RJ; Taggart C; O'Neill S; McElvaney NG
Am J Med Sci; 2001 Jan; 321(1):33-41. PubMed ID: 11202478
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults.
Flotte TR; Brantly ML; Spencer LT; Byrne BJ; Spencer CT; Baker DJ; Humphries M
Hum Gene Ther; 2004 Jan; 15(1):93-128. PubMed ID: 14965381
[TBL] [Abstract][Full Text] [Related]
13. Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.
Chiuchiolo MJ; Crystal RG
Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4(Suppl 4):S352-69. PubMed ID: 27564673
[TBL] [Abstract][Full Text] [Related]
14. [Alpha-1-antitrypsin deficiency].
Bouchecareilh M
Med Sci (Paris); 2014 Oct; 30(10):889-95. PubMed ID: 25311024
[TBL] [Abstract][Full Text] [Related]
15. Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors.
Song S; Embury J; Laipis PJ; Berns KI; Crawford JM; Flotte TR
Gene Ther; 2001 Sep; 8(17):1299-306. PubMed ID: 11571566
[TBL] [Abstract][Full Text] [Related]
16. Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency.
Borel F; Tang Q; Gernoux G; Greer C; Wang Z; Barzel A; Kay MA; Shultz LD; Greiner DL; Flotte TR; Brehm MA; Mueller C
Mol Ther; 2017 Nov; 25(11):2477-2489. PubMed ID: 29032169
[TBL] [Abstract][Full Text] [Related]
17. Alpha-1-antitrypsin expression in the lung is increased by airway delivery of gene-transfected macrophages.
Zhang D; Wu M; Nelson DE; Pasula R; Martin WJ
Gene Ther; 2003 Dec; 10(26):2148-52. PubMed ID: 14625570
[TBL] [Abstract][Full Text] [Related]
18. Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.
Ogushi F; Fells GA; Hubbard RC; Straus SD; Crystal RG
J Clin Invest; 1987 Nov; 80(5):1366-74. PubMed ID: 3500183
[TBL] [Abstract][Full Text] [Related]
19. Alpha1-antitrypsin deficiency.
Stoller JK; Aboussouan LS
Lancet; 2005 Jun 25-Jul 1; 365(9478):2225-36. PubMed ID: 15978931
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary epithelial expression of human alpha1-antitrypsin in transgenic mice results in delivery of alpha1-antitrypsin protein to the interstitium.
Dhami R; Zay K; Gilks B; Porter S; Wright JL; Churg A
J Mol Med (Berl); 1999 Apr; 77(4):377-85. PubMed ID: 10353442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
